Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.13 USD | +3.68% | -7.91% | +65.52% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 418K | Sales 2025 * | 19.8M | Capitalization | 262M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -100M | EV / Sales 2024 * | 628 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 13.3 x |
P/E ratio 2024 * |
-2.35
x | P/E ratio 2025 * |
-3.36
x | Employees | 122 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.4% |
Latest transcript on Inovio Pharmaceuticals, Inc.
1 day | +3.68% | ||
1 week | -7.91% | ||
1 month | -11.53% | ||
3 months | +14.33% | ||
6 months | +114.15% | ||
Current year | +65.52% |
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 19-03-24 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 02-05-31 |
Chief Tech/Sci/R&D Officer | - | 07-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 03-11-30 |
Lota Zoth
BRD | Director/Board Member | 64 | 17-12-31 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-01-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 10.13 | +3.68% | 254,711 |
24-05-30 | 9.77 | -2.69% | 375,632 |
24-05-29 | 10.04 | -3.37% | 231,096 |
24-05-28 | 10.39 | -5.55% | 444,477 |
24-05-24 | 11 | +0.36% | 222,504 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.52% | 262M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- INO Stock